Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Humasis Co's Free Cash Flow for the
three
months ended in Jun. 2026 was ₩1,774 Mil. Humasis Co's Revenue for the
three
months ended in Jun. 2026 was ₩7,738 Mil. Therefore, Humasis Co's FCF Margin % for the quarter that ended in Jun. 2026 was 22.92%.
The historical rank and industry rank for Humasis Co's FCF Margin % or its related term are showing as below:
XKRX:205470'
s FCF Margin % Range Over the Past 10 Years
Min: -569.86 Med: -9.86 Max: 92.74
Current: 33.55
During the past 12 years, the highest FCF Margin % of Humasis Co was 92.74%. The lowest was -569.86%. And the median was -9.86%.
XKRX:205470's FCF Margin % is ranked better than 98.4% of 813
companies
in the Medical Devices & Instruments industry
Industry Median: -0.49
vs XKRX:205470: 33.55
The historical data trend for Humasis Co's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKRX:205470 vs ABT, SYK, MDT: FCF Margin % Comparison
For the Medical Devices subindustry, Humasis Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Humasis Co FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Humasis Co's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Humasis Co's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Humasis Co (XKRX:205470) has a FCF Margin % of 22.92% as of Jun. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Humasis Co and its competitors. According to the industry distribution chart, Humasis Co ranks #13 out of 813 companies in the Medical Devices & Instruments industry, placing it in the top 1.6%.
Is Humasis Co's FCF Margin % too high?
Humasis Co's current FCF Margin % is 22.92%. Based on the distribution chart, Humasis Co ranks #13 out of 813 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Humasis Co has a GF Score™ of 42/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Humasis Co's FCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Humasis Co ranks #13 out of 813 companies for FCF Margin %. This places Humasis Co in the top 2% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Humasis Co and its competitors. Humasis Co's current FCF Margin % is 22.92%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Humasis Co stock overvalued right now?
Based on GuruFocus' analysis, Humasis Co (XKRX:205470) is currently considered Possible Value Trap. The stock's GF Value™ is ₩9,890.20, compared to a current price of ₩3,310.00 — trading 66.5% below its estimated fair value. The current FCF Margin % is 22.92%. Humasis Co's overall GF Score™ is 42/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Humasis Co (XKRX:205470), the current FCF Margin % is 22.92% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Humasis Co (XKRX:205470) Overvalued in 2026?
Based on GuruFocus' analysis, Humasis Co stock appears to be undervalued.
The current stock price of ₩3,310.00 is trading 66.5% below its estimated GF Value™ of ₩9,890.20.
GuruFocus considers Humasis Co to be Possible Value Trap.
Key valuation signals for XKRX:205470:
FCF Margin %: 22.92%
GF Value™: ₩9,890.20 vs. price of ₩3,310.00 (66.5% below fair value)
No single metric tells the full story. See the XKRX:205470 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKRX:205470 has been successfully added to your 
